Literature DB >> 928260

Response to atenolol in arterial hypertension in relation to renal function, pharmacokinetics and renin activity.

P Y Zech, M Labeeuw, N Pozet, A Hadj-Aissa, J Sassard, J McAinsh.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 928260

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  5 in total

1.  Atenolol v placebo in mild hypertension: renal metabolic and stress antipressor effects.

Authors:  H J Waal-Manning; P Bolli
Journal:  Br J Clin Pharmacol       Date:  1980-06       Impact factor: 4.335

Review 2.  Atenolol: a review of its pharmacological properties and therapeutic efficacy in angina pectoris and hypertension.

Authors:  R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1979-06       Impact factor: 9.546

3.  The effect of renal impairment on the pharmacokinetics and metabolism of bopindolol.

Authors:  N J MacDonald; A C Grant; R S Rodger; P A Meredith; H L Elliott
Journal:  Br J Clin Pharmacol       Date:  1991-06       Impact factor: 4.335

4.  Antihypertensive and renal haemodynamic effects of atenolol and nadolol in elderly hypertensive patients.

Authors:  W G O'Callaghan; M S Laher; K McGarry; E O'Brien; K O'Malley
Journal:  Br J Clin Pharmacol       Date:  1983-10       Impact factor: 4.335

Review 5.  Clinical pharmacokinetics of atenolol--a review.

Authors:  W Kirch; K G Görg
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1982       Impact factor: 2.441
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.